De bepaling van propranolol enantiomeren in ratteplasma met behulp van hoge-druk vloeistofchromatografie en fluorescentie detectie; ontwikkeling en validatie
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ReportLanguage
nl
Metadata
Show full item recordTitle
De bepaling van propranolol enantiomeren in ratteplasma met behulp van hoge-druk vloeistofchromatografie en fluorescentie detectie; ontwikkeling en validatieTranslated Title
[The determination of propranolol enantiomers in rat plasma by high-performance liquid chromatography with fluorescence detecion; development and validation.]Publiekssamenvatting
Abstract niet beschikbaarThis report describes a method for the determination of the enantiomers of the beta-blocker propranolol. Propranolol is isolated by solid phase extraction. The propranolol enantiomers are derivatized to diastereomeric compounds by reaction with the chiral reagent (-)-menthylchloroformate. The diastereoisomers are separated by reversed-phase high-performance liquid chromatography (HPLC) on an octadecylcolumn, using methanol-water (875/125 ; v/v) as eluent. The diastereoisomers are detected by fluorescence detection. Standard curves for both R-(+)-propranolol and S-(-)-propranolol are linear in the 0,050-1,50 mg/l range. The limit of detection is 0,010 mg/l for each enantiomer. The limit of determination is 0,050 mg/l for each enantiomer based on a 50 mul plasma. The extraction recoveries are between 95-100%. Within-laboratory reproducibility (n=20) is 5,5% for S-(-)-propranolol and 5,9% for R-(+)-propranolol at 0,352 mg/l. The method has been used for pharmacokinetic studies of propranolol enantiomers in rats.
Sponsors
HIG CBGCollections